AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimtoss 4mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Astonea Labs Private Limited

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Glimtoss 4mg/500mg Tablet

DiaBetaComb 4mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBetaComb with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Inform your doctor of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or breastfeeding individuals should consult their physician. Regular blood sugar checks and blood tests (monitoring blood cell counts and liver function) will be advised by your doctor.

Uses of Glimtoss 4mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glimtoss 4mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; do not chew, crush, or fracture it. Glimtoss 4mg/500mg tablets should be taken with meals.

Common Side effects of Glimtoss 4mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimtoss 4mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glimtoss 4mg/500mg tablets should be administered with a meal.

How Glimtoss 4mg/500mg Tablet works:

Each Glimtoss 4mg/500mg tablet combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts triply: it decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimtoss 4mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimtoss 4mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and the use of Glimtoss 4mg/500mg tablets are contraindicated. Evidence indicates a potential for infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimtoss 4mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimtoss 4mg/500mg tablets. Physician consultation is necessary. Regular kidney function assessments are recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimtoss 4mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate liver disease, Glimtoss 4mg/500mg tablets are typically initiated at a low dose; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimtoss 4mg/500mg Tablet :

Should you forget a Glimtoss 4mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimtoss 4mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Diabetes medication

FAQs on Glimtoss 4mg/500mg Tablet

Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and other individuals.
Glimtoss 4mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially dangerous adverse effect is particularly concerning for individuals with kidney impairment, the elderly, or those who consume significant quantities of alcohol. Symptoms may manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glimtoss 4mg/500mg Tablet use and seek immediate medical attention.
Glimepiride and Metformin 4mg/500mg (Glimtoss) tablets manage type 2 diabetes mellitus (DM) in adults. This dual-action medication enhances blood sugar control when coupled with a healthy diet and exercise. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. This formulation is unsuitable for type 1 DM.
Glimtoss 4mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headache. Serious, though infrequent, side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimtoss 4mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency due to impaired gastric absorption of the vitamin. This deficiency, if left unaddressed, may manifest as anemia, neurological complications including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Glimtoss 4mg/500mg Tablets may induce hypoglycemia (low blood sugar). Manifestations of low blood sugar can include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimtoss 4mg/500mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glimtoss 4mg/500mg Tablet
87
MRP 106
17% off